almorexant analogs (Actelion)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namealmorexant analogs (Actelion)
Drug Alias Namedual orexin receptor 1/2 antagonists (Actelion)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOrexin receptor type 1 antagonistsOrexin receptor type 2 antagonists
TargetsOrexin receptor type 2Orexin receptor type 1
Therapy Area/IndicationsFeeding and Eating DisordersSleep Initiation and Maintenance Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesActelion Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesActelion Ltd
Active IndicationsN/A
Inactive IndicationsFeeding and Eating DisordersSleep Initiation and Maintenance Disorders

Other Information

ATC CodeN/A
Related LinksN/A